The rates of prescription for menopause hormone therapy have been low in the U.S. since the 2002 Women's Health Initiative study, but no recent studies have assessed the prescribing of hormone therapy in the U.S. Using the National Ambulatory Medical Care Survey data from 2018 to 2019, we found that hormone therapy was prescribed in 3.8 % of U.S. visits by midlife and older women, with 60 % of these visits including estradiol-only prescriptions. Older age and Hispanic/Latina ethnicity were associated with decreased odds of prescribing, while White race and depression were associated with increased odds, indicating possible disparities in menopause care.

中文翻译：

---

2018 年至 2019 年美国中年和老年女性门诊护理中处方的更年期激素疗法

自 2002 年妇女健康倡议研究以来，美国更年期激素治疗的处方率一直很低，但最近没有研究评估美国激素治疗的处方情况。使用 2018 年至 2019 年的国家流动医疗调查数据，我们研究发现，3.8% 的美国中年和老年女性就诊时服用了激素治疗，其中 60% 只服用了雌二醇处方。年龄较大和西班牙裔/拉丁裔种族与处方几率降低相关，而白人种族和抑郁症与处方几率增加相关，这表明更年期护理可能存在差异。